Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 25;15(2):107-112.
doi: 10.3400/avd.oa.22-00036.

Characteristics and Prognostic Factors of Venous Thromboembolism in Cancer Patients

Hajime Tsuyuki  1   2 , Naoto Yamamoto  1 , Naoki Unno  1   2 , Kazunori Inuzuka  2 , Masaki Sano  2 , Kazuto Katahashi  2 , Tatsuro Yata  2 , Takafumi Kayama  2 , Yuta Yamanaka  2 , Yusuke Endo  2 , Hiroya Takeuchi  2
Affiliations

Characteristics and Prognostic Factors of Venous Thromboembolism in Cancer Patients

Hajime Tsuyuki et al. Ann Vasc Dis. .

Abstract

Background: Improving the prognosis of patients with malignant tumors is increasing the number of patients who develop venous thromboembolism. We examined the characteristics and prognostic factors of VTE patients with cancer. Methods: We diagnosed 725 VTE patients from April 2005 to March 2018. There were 322 cancer associated patients (CAT) and 403 non-cancer associated patients (nonCAT). We examined characteristics and prognostic factors of VTE in CAT patients. Results: There were 156 women and 166 men in CAT, and 132 women and 271 men in nonCAT. There was no significant difference in the location of proximal portion of thrombus. When locations were divided into left leg, right leg, and bilateral legs, bilateral cases were more common in CAT group. Comparing the overall survival after VTE diagnosis in the CAT group, the prognosis was poor in patients with high D-dimer level (≧6 µg/mL) along with cancer metastasis and recurrence. Conclusions: Various VTE factors predict prognosis in CAT patients, and CAT is important in the treatment of cancer patients. (This is secondary publication from Jpn J Phlebol 2020; 31(3): 153-159.).

Keywords: cancer-associated thrombosis; deep vein thrombosis; pulmonary thromboembolism; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Disclosure StatementWe have no financial relationships to disclose.

References

    1. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res 2010; 125: 490-3. - PMC - PubMed
    1. Guidelines for Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism and Deep Vein Thrombosis (JCS 2017). (in Japanese)
    1. Wells PS, Owen C, Doucette S, et al. Does this patient have deep vein thrombosis? JAMA 2006; 295: 199-207. - PubMed
    1. Trousseau A. Phlegmasia alba dolens. Clinique medicate de l’Hotel Dieu de Paris, Vol. 3. Paris: Bailliere, 1865: 654-712.
    1. Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis: an overview. Clin Med Insights Oncol 2014; 8: 129-37. - PMC - PubMed